Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy

Lung Cancer

Volumn 35, Issue 3, 2002, Pages 305-314

  Kawai, Haruyuki ^a   Kiura, Katsuyuki ^a   Tabata, Masahiro ^a   Yoshino, Tadashi ^a   Takata, Ichiro ^a   Hiraki, Akio ^a   Chikamori, Kenichi ^a   Ueoka, Hiroshi ^a   Tanimoto, Mitsune ^a   Harada, Mine ^a,b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Accumulation; Cisplatin; Glutathione; In vivo; Methotrexate; MRP3; Non small cell lung cancer

Indexed keywords

CISPLATIN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; IFOSFAMIDE; LUNG RESISTANCE PROTEIN; MESSENGER RNA; METALLOTHIONEIN; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; PACLITAXEL; VINDESINE;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL LEVEL; CELL SURVIVAL; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CROSS RESISTANCE; DRUG ACCUMULATION; DRUG SENSITIVITY; DRUG UPTAKE; HISTOLOGY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME ABERRATIONS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MICROSCOPY, ELECTRON; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0036175650     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00430-5     Document Type: Article

References (43)

1. Estimates of the worldwide mortality from 25 cancers in 1990
2. The National Cancer Data Base report on lung cancer
3. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions
4. Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer
5. Alternate mechanisms of drug resistance in human lung cancer
6. Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line
7. Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance
8. Establishment and characterization of SN-38 (an active metabolite of CPT-11)-resistant human lung cancer (SCLC) cell lines
9. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids
10. Very young patient with peculiar squamous cell carcinoma of the lung
11. Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer
12. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
13. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues
14. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
15. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas
16. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
17. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
18. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP
19. Glutathione-S-transferases pi, alpha, mu and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemia
20. Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues
21. Frequent coordinated overexpression of the MRP/GS-X pump and gamma-glutamylcysteine synthetase genes in human colorectal cancers
22. Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney
23. Simultaneous amplification of four DNA repair genes and beta-actin in human lymphocytes by multiplex reverse transcriptase-PCR
24. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
25. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
26. Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system
27. Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors
28. Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient
29. Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy
30. Experimental model systems of ovarian cancer: Applications to the design and evaluation of new treatment approaches
31. High-dose cisplatin in hypertonic saline
32. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines
33. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: A case-control study
34. Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism
35. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans
36. MRP3, an organic anion transporter able to transport anti-cancer drugs
37. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents
38. Expression of multidrug resistance protein-related genes in lung cancer: Correlation with drug response
39. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)
40. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma
41. Glutathione-associated cis-diamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance
42. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy
43. Comparison of features of human breast cancer cell lines and their corresponding tumors